Exploring the therapeutic potential of Modafinil in mitigating renal ischemia–reperfusion injury in rats
- 13 August 2024
- journal article
- research article
- Published by Wiley in Fundamental & Clinical Pharmacology
- Vol. 38 (6) , 1168-1177
Abstract
Background: Renal ischemia reperfusion injury (IRI) is a post‐ischemic event, which can lead to subsequent acute kidney injury (AKI), transplant failure, renal dysfunction and fibrosis via heightened oxidative stress and production of inflammatory cytokines and chemokines.Objective: This study aims to assess the effect of Modafinil, a wake‐promoting agent with previously proven anti‐inflammatory and anti‐oxidative properties, on ameliorating renal IRI.Methods: A total of 30 male Wistar rats were divided into five groups: Sham‐operated group, ischemia reperfusion (I/R) control group and Modafinil pre‐treated groups (at different doses of 50, 100 and 150 mg/kg). IRI was induced by means of bilaterally clamping the renal arteries for 45 min, followed by 24 h of reperfusion.Results: Tissue pathological assessments demonstrated a reduction of glomerular, vascular and interstitial injury at doses of 50 and 100 mg/kg of Modafinil. The biochemical studies showed a significant decrease in tissue pro‐inflammatory factors, including tumor necrosis factor alpha (TNF‐α), Interleukin‐18 (IL‐18) and lactate dehydrogenase (LDH). Moreover, an elevation was observed in levels of super oxide dismutase (SOD) and catalase, indicating the reduction of oxidative stress. Furthermore, the levels of creatinine (Cr), urea and neutrophil gelatinase‐associated lipocalin (NGAL) were declined, indicating the improvement in renal function at effective doses of Modafinil (50 and 100 mg/kg) compared to the I/R control group without Modafinil pre‐treatment.Conclusion: Our findings suggest that Modafinil holds promise as an effective therapeutic agent to address the clinical challenges associated with kidney IRI reducing the need for hospitalization and potentially alleviating related morbidities.Keywords
Funding Information
- Tehran University of Medical Sciences and Health Services (1401‐2‐101‐58628)
This publication has 30 references indexed in Scilit:
- Involvement of nitric oxide pathway in the anti-inflammatory effect of modafinil on indomethacin-, stress-, and ethanol -induced gastric mucosal injury in ratEuropean Journal of Pharmacology, 2020
- The potential protective effect of modafinil in intestinal ischemic reperfusion-induced in ratsInternational Immunopharmacology, 2020
- Renal ischemia/reperfusion injury: An insight on in vitro and in vivo modelsLife Sciences, 2020
- Protective effects of modafinil administration on testicular torsion/detorsion damage in ratsExperimental and Molecular Pathology, 2019
- Regulated necrosis in kidney ischemia-reperfusion injuryKidney International, 2019
- Protective effect of N‐(p‐amylcinnamoyl) anthranilic acid, phospholipase A2 enzyme inhibitor, and transient receptor potential melastatin‐2 channel blocker against renal ischemia–reperfusion injuryJournal of Cellular Biochemistry, 2018
- Chronic administration of modafinil induces hyperalgesia in mice: Reversal by l-NG-nitro-arginine methyl ester and 7-nitroindazoleEuropean Journal of Pharmacology, 2014
- Protective effects of acute lithium preconditioning against renal ischemia/reperfusion injury in rat: Role of nitric oxide and cyclooxygenase systemsEuropean Journal of Pharmacology, 2012
- Renoprotective effects of γ-aminobutyric acid on ischemia/reperfusion-induced renal injury in ratsEuropean Journal of Pharmacology, 2009
- Ozone Oxidative Preconditioning Protects the Rat Kidney from Reperfusion Injury: The Role of Nitric OxideJournal of Surgical Research, 2008